Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03369405 · ClinicalTrials.gov registry record
Thyroid Disease and Chronic Periodontitis
A clinical trial, sponsored by University at Buffalo.
- Completed
- Registry status
- 4,965
- Enrollment target
NCT03369405: Completed study, sponsored by University at Buffalo.
NCT03369405 is a clinical trial that has completed, run by University at Buffalo. The registered enrollment target is 4,965 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03369405 has completed, sponsored by University at Buffalo.
- COMPLETED
- Registry status
- 4,965 participants
- Enrollment target
Study Summary
Currently, the investigators are unaware of any previous studies that have analyzed the relationship between the prevalence of thyroid disease and chronic periodontitis among adults utilizing a retrospective, cross-sectional design. This study will review approximately 2000 patient records and compare the prevalence of thyroid disease in three groups with increasing severity of chronic periodontitis.
Primary Outcome
The presence or absence of thyroid medication in the patient record will be used as a surrogate marker for thyroid disease presence or absence.
Interventions
- OTHER NO intervention, patient records review only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,965 participants |
| Start Date | 2018-02-02 |
| Est. Completion | 2023-09-01 |
What the finished NCT03369405 record still lists
NCT03369405 is an observational study that tracks outcomes without assigning an intervention. Its 4,965 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which NO intervention, patient records review only is the first listed.
NCT03369405 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03369405 about?
NCT03369405 is a clinical study titled "Thyroid Disease and Chronic Periodontitis". Currently, the investigators are unaware of any previous studies that have analyzed the relationship between the prevalence of thyroid disease and chronic periodontitis among adults utilizing a retrospective, cross-sectional design. This study will review approximately 2000 patient records and compa...
What is the current status of trial NCT03369405?
This trial is currently completed. The enrollment target is 4,965 participants. The study started on 2018-02-02. Estimated completion is 2023-09-01.
What interventions are being tested in trial NCT03369405?
The interventions under investigation include: NO intervention, patient records review only (OTHER).
Who is sponsoring clinical trial NCT03369405?
This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI